Provider-caregiver-child discussions about risks associated with asthma control medications: content and prevalence.
Provider-caregiver-child discussions about risks associated with asthma control medications: content and prevalence.
复制标题
提供者-看护者-儿童关于哮喘控制药物相关风险的讨论：内容和患病率。
DOI：
10.1002/ppul.22892
复制
发表时间：
2014
影响因子：
3.1
通讯作者：
Sleath,Betsy
中科院分区：
文献类型：
--
作者：
Gillette,Chris;Blalock,SusanJ;Rao,JayaK;Williams,Dennis;Loughlin,CeilaE;Sleath,Betsy
目的 本研究的目的是：(1) 描述一般儿科服务提供者与家人讨论与哮喘控制药物相关的风险的程度，以及 (2) 检查与风险讨论相关的因素。研究设计本研究是对录音医疗就诊的横断面二次分析，涉及 35 名儿科提供者和 248 名哮喘儿童及其照顾者。访问记录经过编码，用于讨论哮喘药物风险。使用广义估计方程来分析数据。结果 23% 的就诊期间提供者讨论了哮喘控制药物风险。当就诊时间较长以及提供者开出新的哮喘控制药物时，更有可能讨论风险。当提供者讨论哮喘控制药物风险时，他们最有可能询问家人一般性问题并做出一般性陈述。在所有访问中，护理人员总共提出了 16 个问题，并就哮喘药物相关风险做出了总共 20 项陈述；孩子们总共提出了 3 个问题，并就与哮喘控制药物相关的风险做出了两项陈述。结论 提供者在不到四分之一的就诊中讨论了与哮喘控制药物相关的风险。提供者应在每次就诊期间让家人参与有关药物相关风险的讨论，以评估药物依从性的潜在障碍。Pediatr Pulmonol。 2014年； 49:727–733.© 2013 Wiley periodicals, Inc.
ObjectivesThe objectives of this study were to: (1) describe the extent to which general pediatric providers discuss risks associated with asthma control medications with families, and (2) examine factors that are associated with risk discussions.Study DesignThis study was a cross‐sectional secondary analysis of audio taped medical visits involving 35 pediatric providers and 248 children with asthma with their caregivers. Transcripts of the visits were coded for discussions about asthma medication risks. Generalized estimating equations were used to analyze the data.ResultsProviders discussed asthma control medication risks during 23% of visits. Risks were more likely to be discussed when the visit was longer and when the provider prescribed a new asthma control medication. When providers discussed asthma control medication risks, they were most likely to ask the family general questions and make general statements. Across all of the visits, caregivers asked a total of 16 questions and made a total of 20 statements about risks associated with asthma medications; children asked a total of 3 questions and made two statements about risks associated with asthma control medications.ConclusionProviders discussed risks associated with asthma control medications in less than one‐quarter of medical visits. Providers should involve families in discussions about risks associated with medications during every visit to assess potential barriers to medication adherence.Pediatr Pulmonol. 2014; 49:727–733.© 2013 Wiley Periodicals, Inc.